Increasing Impact Event Recording Now Available
Stream "Increasing Impact: Leveraging Data to Drive Healthcare Access and Advancement"
Increasing Global Access to Medicines
2024 Global Access Fellow Spotlight on Magdalene Mallory
2024 Access to Medicines Internship Spotlight
2024 Access to Medicines Internship Spotlight on Amanda Bowlin
Increasing Global Access to Medicines
2024 Global Access Fellow Spotlight on Mackenzie Greene
2024 Access to Medicines Internship Spotlight
2024 Access to Medicines Internship Spotlight on Ethan Hsu
2024 Access to Medicines Internship Spotlight
2024 Access to Medicines Internship Spotlight on Derek Bassett
Roivant Sciences and Roivant Social Ventures Provide Internship Opportunities for Talented PharmD Students
Roivant Sciences, Roivant Social Ventures (RSV), and Elutia have partnered to create summer internship opportunities to provide real-world drug development experience to talented PharmD students. The intentions of this program are to expand access to medicines to underserved populations, and to further UNC Eshelman School of Pharmacy's goal of providing future industry leaders with pharmaceutical experience during their PharmD tenure.
Roivant Social Ventures Launches Inaugural Convergence Forum Fellowship Program
Roivant Social Ventures is proud to announce the launch of our inaugural Convergence Forum Fellowship Program in support of CEOs championing healthcare equity through the development of therapeutics and technology.
BioSpace Article Feature: “Feeder Programs First Step in Bringing More Diversity to Pharma”
"Most of the treatments and cures that pharmaceutical companies focus on are for illnesses that affect white men, rather than women or people of color, said Lindsay Androski, CFA, President and CEO of Roivant Social Ventures and an independent director at Eloxx Pharmaceuticals.
“I do not believe this is because of malice but because people have a human tendency to want to make a difference in areas that have impacted them or their loved ones personally,” Androski told BioSpace. “But one area where I can make an impact today is to expose more talented future leaders to the industry and get them in the front door at the beginning of their careers.”
Increasing Global Access to Medicines
2023 Global Access Fellow Spotlight on Caroline Eason
Increasing Representation in Pharma
2023 Diversity in Pharma Intern Spotlight on Dahye Kim
Increasing Representation in Pharma
2023 Diversity in Pharma Intern Spotlight on Diana Locoteta
Increasing Representation in Pharma
2023 Diversity in Pharma Intern Spotlight on Hannah Summers
Diversity in Pharma Internship Program
Roivant Sciences and Roivant Social Ventures Launch Inaugural Diversity in Pharma Internships for Talented PharmD Students
Roivant Social Ventures Launches "Making Medicines" Course at the UNC Eshelman School of Pharmacy
Taught by Lindsay Androski, RSV Founder and CEO, and Scott Singleton, Associate Professor at the UNC Eshelman School of Pharmacy
2022: Reflecting on a Remarkable Year of Progress
Reflecting on a Remarkable Year of Progress: A Letter from Roivant Social Ventures President & CEO Lindsay Androski
Roivant Social Ventures Publishes Global Access Scorecard to Guide Impact Investors in Making Equitable Investment Decisions
Roivant Social Ventures Publishes Global Access Scorecard to Guide Impact Investors in Making Equitable Investment Decisions
RSV Named Finalist for Venture Philanthropy Award
The Gregor G. Peterson Prize in Venture Philanthropy is awarded annually to a trailblazing start-up in the non-profit sector.
Roivant Social Ventures and Vanderbilt University Medical Center announce collaboration to develop therapies for traditionally underserved populations and diseases.
Vanderbilt University Medical Center (VUMC) and Roivant Social Ventures (RSV) announced an intention to collaborate in developing therapies…